BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stocks, par value $0,0001 per share
Symbol
BCAB on Nasdaq
Shares outstanding
58,548,563
Price per share
$0.32
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
13,178,637
Total reported value
$7,494,979
% of total 13F portfolios
0%
Share change
-103,395
Value change
-$262,374
Number of holders
40
Price from insider filings
$0.32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.7% -22% $2,129,415 -$1,104,235 4,839,579 -34% Highbridge Capital Management, LLC 31 Mar 2025
ACORN BIOVENTURES, L.P. 8.3% $2,127,449 4,835,111 Anders Hove 15 May 2025
SHORT JAY M PHD 6.6% $1,700,884 3,865,646 Jay M. Short 31 Dec 2024
OPOKA INVESTMENT FUND Co 4.8% -22% $1,933,227 -$507,296 2,810,331 -21% OPOKA INVESTMENT FUND Co 09 Jul 2025
MILLENNIUM MANAGEMENT LLC 1.9% $482,067 1,095,606 Millennium Management LLC 31 Dec 2024

As of 31 Dec 2025, 40 institutional investors reported holding 13,178,637 shares of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB). This represents 23% of the company’s total 58,548,563 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) together control 22% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ACORN CAPITAL ADVISORS, LLC 8.3% 4,835,111 0% 0.93% $2,756,013
VANGUARD GROUP INC 3.3% 1,945,795 0% 0% $1,105,212
MARSHALL WACE, LLP 1.5% 891,580 0% $508,201
MILLENNIUM MANAGEMENT LLC 1.3% 762,394 +123% 0% $432,811
ACADIAN ASSET MANAGEMENT LLC 1.3% 757,671 -19% 0% $429,000
RENAISSANCE TECHNOLOGIES LLC 1.2% 707,214 -12% 0% $401,485
DEUTSCHE BANK AG\ 0.9% 525,353 0% 0% $299,451
GEODE CAPITAL MANAGEMENT, LLC 0.85% 500,328 +1% 0% $284,096
BlackRock, Inc. 0.82% 480,933 0% 0% $273,026
JANE STREET GROUP, LLC 0.59% 346,774 +78% 0% $196,863
UBS Group AG 0.39% 225,684 +160% 0% $128,188
ADAR1 Capital Management, LLC 0.31% 183,107 0.01% $103,950
STATE STREET CORP 0.26% 151,377 0% 0% $85,937
SIMPLEX TRADING, LLC 0.21% 120,391 +233% 0% $68,382
NORTHERN TRUST CORP 0.18% 103,494 +2.6% 0% $58,754
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.14% 81,687 -68% 0% $46,373
TWO SIGMA INVESTMENTS, LP 0.14% 81,330 +100% 0% $46,171
PVG ASSET MANAGEMENT CORP 0.12% 69,000 +3% 0.08% $39,171
XTX Topco Ltd 0.1% 60,395 +212% 0% $34,286
Virtu Financial LLC 0.09% 55,460 0% $31,000
HRT FINANCIAL LP 0.09% 54,742 +26% 0% $31,000
MAI Capital Management 0.09% 51,504 +14% 0% $29,239
MORGAN STANLEY 0.07% 43,653 +183% 0% $24,781
COLUMBIA ADVISORY PARTNERS LLC 0.04% 26,070 0% 0.01% $14,800
COMMONWEALTH EQUITY SERVICES, LLC 0.04% 25,300 0% 0% $14,360

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,178,637 $7,494,979 -$262,374 $0.57 40
2025 Q3 13,349,032 $9,190,012 +$218,760 $0.69 43
2025 Q2 13,168,921 $5,214,805 -$178,456 $0.40 39
2025 Q1 13,676,589 $4,757,169 -$6,041,757 $0.35 40
2024 Q4 24,014,047 $14,192,960 -$3,984,785 $0.59 67
2024 Q3 17,681,418 $31,044,305 -$6,375,131 $1.76 63
2024 Q2 22,134,924 $30,397,774 -$9,819,957 $1.37 78
2024 Q1 25,353,603 $87,226,850 -$3,078,466 $3.44 83
2023 Q4 27,002,533 $66,550,242 -$6,102,978 $2.46 79
2023 Q3 29,893,256 $50,818,372 -$3,978,003 $1.70 80
2023 Q2 32,003,208 $96,009,836 -$889,082 $3.00 86
2023 Q1 32,818,307 $87,622,240 -$35,920,780 $2.68 79
2022 Q4 33,849,374 $279,248,047 +$75,723,026 $8.25 88
2022 Q3 24,872,441 $191,538,348 +$24,104,114 $7.70 66
2022 Q2 23,517,118 $67,049,000 -$8,813,651 $2.85 71
2022 Q1 25,528,713 $127,715,000 -$39,588,884 $5.00 91
2021 Q4 26,409,935 $518,424,807 +$9,459,769 $19.63 79
2021 Q3 25,357,996 $746,373,968 +$120,415,617 $29.44 83
2021 Q2 21,165,507 $896,994,925 +$89,307,130 $42.38 73
2021 Q1 19,002,884 $964,589,936 +$187,867,257 $50.84 62
2020 Q4 15,664,281 $530,219,000 +$530,219,000 $34.01 53